Drug maker GSK will invest $800 million in its Lancaster County facility
GSK plans to invest $800 million in its East Donegal Township vaccine packaging facility over the next four years, in an expansion project that would add research and manufacturing capabilities along with 200 jobs.
The British multinational pharmaceutical and biotechnology company announced its plans Thursday at the facility, joined by Gov. Josh Shapiro, who said the project would receive $21 million in state grants on top of local tax incentives already approved for the project.
“We are really proud about this amount of investment, this trust in the Marietta facility,” Matteo Leardini, Marietta Site Leader for GSK, said during Thursday’s announcement.
GSK expects to begin construction immediately on the project, which includes a new 300,000-square-foot-facility and renovating existing buildings. The current facility mainly packages vaccines produced at other sites and employs 380 people.
The $800 million project is the company’s largest-ever investment in its U.S. manufacturing facilities, and Shapiro said it is the largest project the state has ever helped finance in Lancaster County.
“When you are a massive global company like GSK, you can kind of go anywhere, and you certainly have the expertise and the ability to go anywhere, but the fact that you’re doubling down on Lancaster County, that means a lot to us,” Shapiro said.
Construction is expected to be completed by 2028. The project got land development approval from the East Donegal Township Supervisors in September.
This is a breaking news story and will be updated.